Literature DB >> 9245964

Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.

S O Hustvedt1, D Grant, T E Southon, K Zech.   

Abstract

PURPOSE: To investigate distribution and excretion of mangafodipir (MnDPDP, Teslascan) in the rat and dog.
MATERIAL AND METHODS: Formulations of either 14C-MnDPDP or 54MnDPDP were injected intravenously at near clinical doses in rats and dogs.
RESULTS: The manganese (Mn) moiety is rapidly removed from plasma with an elimination half-life of less than 25 min in both species, reflecting a rapid distribution to the tissues and an early excretion. The plasma clearance of the DPDP moiety is slower than that of Mn and it appears to distribute into the extracellular fluid. Mn is distributed largely to the liver, pancreas and kidneys, and in pregnant rats, also to foetal liver and bones. No transplacental passage of DPDP could be detected. The metal is mainly excreted by the faecal route, with a small fraction eliminated early in the urine. DPDP is rapidly and essentially completely excreted in the urine, consistent with the glomerular filtration rate.
CONCLUSION: The ligand does not appear to facilitate the transport of Mn into any organ except the kidney for subsequent excretion, and it reduces distribution to the heart. The Mn is taken up by those organs indicated for MR imaging, primarily liver and pancreas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245964     DOI: 10.1080/02841859709172401

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  8 in total

Review 1.  Safety of MR liver specific contrast media.

Authors:  Marie-France Bellin; Judith A W Webb; Aart J Van Der Molen; Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

Review 2.  Manganese toxicity upon overexposure.

Authors:  Janelle Crossgrove; Wei Zheng
Journal:  NMR Biomed       Date:  2004-12       Impact factor: 4.044

Review 3.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.

Authors:  Gul Eser; Aydin Karabacakoglu; Serdar Karakose; Cengiz Eser; Ertugrul Kayacetin
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

5.  Toward clinical application of manganese-enhanced MRI of retinal function.

Authors:  Paul S Tofts; Andre Porchia; Ying Jin; Robin Roberts; Bruce A Berkowitz
Journal:  Brain Res Bull       Date:  2009-06-11       Impact factor: 4.077

6.  Biodistribution and PET Imaging of pharmacokinetics of manganese in mice using Manganese-52.

Authors:  A Lake Wooten; Tolulope A Aweda; Benjamin C Lewis; Rebecca B Gross; Suzanne E Lapi
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

7.  Manganese-Enhanced T1 Mapping in the Myocardium of Normal and Infarcted Hearts.

Authors:  N B Spath; D M L Lilburn; G A Gray; L M Le Page; G Papanastasiou; R J Lennen; R L Janiczek; M R Dweck; D E Newby; P C Yang; M A Jansen; S I Semple
Journal:  Contrast Media Mol Imaging       Date:  2018-10-25       Impact factor: 3.161

Review 8.  Manganese-enhanced MRI of the myocardium.

Authors:  Nick B Spath; Gerard Thompson; Andrew H Baker; Marc R Dweck; David E Newby; Scott I K Semple
Journal:  Heart       Date:  2019-07-23       Impact factor: 5.994

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.